Vor Biopharma Inc.

NASDAQ:VOR

0.9421 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0012.2260000000000000000000
Kosten van de omzet 0.90.9430.8922.0891.2342.793.0592.3880.5750.4261.1521.130.3540.63300000000
Brutowinst -0.9-0.94311.334-2.089-1.234-2.79-3.059-2.388-0.575-0.426-1.152-1.13-0.354-0.63300000000
Brutowinstmarge 000.9270000000000000000000
Onderzoek- en ontwikkelingskosten 21.82324.32220.89727.60623.89721.91517.06216.87515.33315.2812.69312.92512.978.94111.338.1425.9756.1712.9641.5680.8340.834
Algemene en administratieve kosten 7.2128.0047.2277.718.2778.5077.6637.2266.4597.525.6135.6775.414.7894.3333.6432.0651.7070.9642.1480.5530.553
Verkoop- en marketingkosten -0.9-0.943-0.8920000000000000000000
Verkoop-, algemene en administratieve kosten 6.3127.0616.3357.718.2778.5077.6637.2266.4597.525.6135.6775.414.7894.3333.6432.0651.7070.9642.1480.5530.553
Overige kosten 0000000000000000000000
Bedrijfskosten 28.13531.38327.23235.31632.17430.42224.72524.10121.79222.818.30618.60218.3813.7315.66311.7858.047.8783.9283.7161.3711.371
Bedrijfsresultaat -29.035-32.326-28.124-35.316-32.174-30.422-24.725-24.101-21.792-22.8-18.306-18.602-18.38-13.73-15.663-11.785-8.04-7.878-3.928-3.716-1.387-1.387
Bedrijfsresultaat ratio 00-2.30000000000000000000
Totaal overige inkomsten en kosten netto 1.1961.5221.8632.1262.1951.9890.8150.3130.1330.06368.9530.0480.010.00743.337000.0290.0350.077-0.267-0.267
Inkomen voor belasting -27.839-30.804-26.261-33.19-29.979-28.433-23.91-23.788-21.659-22.737-18.252-18.554-18.37-13.723-15.663-11.785-8.04-7.849-3.893-3.639-1.654-1.654
Inkomen voor belasting ratio 00-2.1480000000000000000000
Belastingkosten 00.90.5651.4243.065-1.989-1.011-0.313-0.133-0.06368.899-0.7560-0.32243.3370000.0350.5070.380.38
Nettowinst -27.839-30.804-26.261-33.19-29.979-26.444-22.899-23.475-21.526-22.674-18.252-18.554-18.37-13.723-15.663-11.785-8.04-7.849-3.893-4.146-2.034-2.034
Nettowinstmarge 00-2.1480000000000000000000
WPA (Winst Per Aandeel) -0.41-0.45-0.39-0.49-0.45-0.4-0.49-0.62-0.57-0.61-0.49-0.5-0.5-0.62-0.7-0.97-0.66-0.64-0.32-35.74-18.16-18.16
Verwaterde WPA -0.41-0.45-0.39-0.49-0.45-0.4-0.49-0.62-0.57-0.61-0.49-0.5-0.5-0.62-0.7-0.97-0.66-0.64-0.32-35.63-18.06-18.06
EBITDA -28.135-31.383-27.232-35.316-28.987-29.585-24.093-23.209-21.217-22.374-17.911-18.228-18.026-13.419-15.421-11.593-7.935-7.812-3.852-3.684-1.378-1.378
EBITDA ratio 00-2.2270000000000000000000